FDA approves 1st COVID-19 antibody drug intended for long-term prevention – National | Globalnews.ca
Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies...
Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies...
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare...
OTTAWA -- The U.S. Food and Drug Administration has approved Pfizer-BioNTech's COVID-19 vaccine for children aged five to 11, and...
The U.S. Food and Drug Administration on Friday paved the way for children ages five to 11 to get Pfizer-BioNTech's...
The U.S. Food and Drug Administration on Friday paved the way for children ages five to 11 to get Pfizer-BioNTech's...
The FDA has given emergency authorization for the use of the Pfizer COVID-19 vaccine in children aged five to...
A U.S. Food and Drug Administration (FDA) advisory committee has voted in favour of Pfizer-BioNTech's COVID-19 vaccine for children five to...
WASHINGTON -- The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on...
An expert panel will weigh authorization of Pfizer Inc. and BioNTech’s COVID-19 vaccine for children aged five to 11...
U.S. health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic...